Requirement · EU GMP
Demonstrate sampling recovery
Recovery should be demonstrated for sampled contact materials and methods.
EU GMP Annex 15: Qualification and Validation ↗Recovery · Swab Sampling · Rinse Sampling
SOURCE-LINKED SEARCH
Search the approved public reference and news dataset. Synonyms such as PDE and HBEL are included.
Showing all 79 results
Requirement · EU GMP
Recovery should be demonstrated for sampled contact materials and methods.
EU GMP Annex 15: Qualification and Validation ↗Recovery · Swab Sampling · Rinse Sampling
Requirement · EU GMP
Carryover limits require toxicological justification and consideration of equipment trains.
EU GMP Annex 15: Qualification and Validation ↗HBEL & PDE · MACO · Acceptance Criteria
Requirement · EU GMP
Account for both pre-cleaning and post-cleaning storage intervals.
EU GMP Annex 15: Qualification and Validation ↗Cleaning Validation · Hold Times
Requirement · EU GMP
Worst-case selection needs a scientific rationale and assessment of new products.
EU GMP Annex 15: Qualification and Validation ↗Worst Case · Shared Equipment
Requirement · EU GMP
Visual inspection alone is generally insufficient for cleaning validation.
EU GMP Annex 15: Qualification and Validation ↗Visual Inspection · Acceptance Criteria
Requirement · EU GMP
Protocols should identify sampling locations, their rationale and acceptance criteria.
EU GMP Annex 15: Qualification and Validation ↗Swab Sampling · Worst Case
Requirement · EU GMP
Consider microbial and endotoxin contamination when developing protocols.
EU GMP Annex 15: Qualification and Validation ↗Cleaning Validation · Microbial Control
Requirement · FDA
Written validation procedures should address responsibilities and acceptance decisions.
Validation of Cleaning Processes ↗Cleaning Validation
Requirement · FDA
Prepare protocols addressing sampling and analytical method sensitivity.
Validation of Cleaning Processes ↗Cleaning Validation · Analytical Methods
Requirement · FDA
Sampling materials and extraction solvents can influence analytical results.
Validation of Cleaning Processes ↗Recovery · Swab Sampling
Requirement · FDA
Rinse testing must meaningfully represent residues on equipment surfaces.
Validation of Cleaning Processes ↗Recovery · Rinse Sampling
Requirement · FDA
Residue drying can affect the effectiveness of a cleaning procedure.
Validation of Cleaning Processes ↗Worst Case · Hold Times
Requirement · FDA
A management-approved report should establish whether cleaning is validated.
Validation of Cleaning Processes ↗Cleaning Validation
Requirement · FDA
Cleaning validation should reflect how equipment is actually used.
Q7A: Good Manufacturing Practice for APIs ↗Worst Case · Shared Equipment
Requirement · FDA
Protocols should describe equipment, procedures, criteria and sample collection.
Q7A: Good Manufacturing Practice for APIs ↗Cleaning Validation · Acceptance Criteria
Requirement · FDA
Sampling should address soluble and insoluble residues appropriately.
Q7A: Good Manufacturing Practice for APIs ↗Swab Sampling · Rinse Sampling
Requirement · FDA
Analytical sensitivity and attainable recovery should support residue evaluation.
Q7A: Good Manufacturing Practice for APIs ↗Recovery · Analytical Methods
Requirement · FDA
Monitor validated cleaning procedures at appropriate intervals during production.
Q7A: Good Manufacturing Practice for APIs ↗Cleaning Validation · Revalidation
Requirement · FDA
Periodically evaluate whether systems remain in a valid state.
Q7A: Good Manufacturing Practice for APIs ↗Cleaning Validation · Revalidation
Requirement · EMA
Establish HBELs for medicinal products and reassess supporting data periodically.
HBEL and cross-contamination: questions and answers ↗HBEL & PDE · Shared Equipment
Requirement · EMA
HBEL development requires suitable toxicological and pharmacological expertise.
HBEL and cross-contamination: questions and answers ↗HBEL & PDE
Requirement · EMA
An HBEL is not automatically the operational cleaning limit.
HBEL and cross-contamination: questions and answers ↗HBEL & PDE · MACO · Acceptance Criteria
Requirement · EMA
Reduced analytical testing requires robust justification, including visual-inspection capability.
HBEL and cross-contamination: questions and answers ↗Visual Inspection · Shared Equipment
Requirement · Health Canada
Connect cleaning development, qualification and ongoing monitoring.
Cleaning validation guide (GUI-0028) ↗Cleaning Validation · Revalidation
Requirement · Health Canada
Control operator-related variability in manual cleaning.
Cleaning validation guide (GUI-0028) ↗Cleaning Validation · Worst Case
Requirement · Health Canada
Evaluate new products within the existing cleaning control strategy.
Cleaning validation guide (GUI-0028) ↗Worst Case · Shared Equipment
Requirement · Health Canada
Surface sampling needs a justified, reproducible collection approach.
Cleaning validation guide (GUI-0028) ↗Recovery · Swab Sampling
Requirement · Health Canada
Consider the selection and removal of cleaning agents.
Cleaning validation guide (GUI-0028) ↗Acceptance Criteria · Detergents
Requirement · MHRA
HBEL implementation supports assessment of cross-contamination controls.
Cross-contamination control and HBEL Q&As ↗HBEL & PDE · Shared Equipment
Requirement · MHRA
Reliance on visual inspection needs evidence supporting the intended limit.
Cross-contamination control and HBEL Q&As ↗Visual Inspection · Acceptance Criteria
Article · Other
Two years of regulatory revision, enforcement, new standards, tighter analytics and a first serious statistics stack have moved cleaning validation out of the appendix and into the centre of GMP. Five developments define where the field stands in September 2026 — and each one changes something a programme owner has to decide.
Primary source ↗Cleaning Validation · MACO · Worst Case · Analytical Methods · Revalidation
Article · Other
At-line TOC, in-line UV and automated process capability monitoring are moving cleaning data from a laboratory result reported days later to a signal produced during the cycle. A close reading of what is proven, what standards actually require, and what remains a promising research proposal.
Primary source ↗Cleaning Validation · Analytical Methods · Acceptance Criteria
Article · Other
Biologics degrade under cleaning, ADCs split one residue into antibody, linker, payload and conjugate, and peptide APIs combine high potency with methods already under strain. A synthesis of the local evidence on why toxicology, cleaning and detectability now move together.
Primary source ↗Cleaning Validation · HBEL & PDE · Worst Case · Analytical Methods
Article · Other
Visual inspection was present in every one of the cleaning findings FDA issued between 2024 and 2026 — never as the accused technique, always as the whole of the evidence. The distinction between a qualified visual method and a visual-only release decision is the difference between a control and an assumption.
Primary source ↗Cleaning Validation · MACO · Visual Inspection · Acceptance Criteria
Article · Other
The analytical method is not a laboratory preference — it is the part of the cleaning validation strategy that decides whether a limit is actually measurable. The useful question is not which technique is 'best' but which technique matches the residue, the acceptance limit, the sampling method and the surface. This analysis walks through the trade-offs using published recovery, detection and clearance data, and shows why a method chosen before the residue is characterised tends to fail at the limit rather than at the bench.
Primary source ↗Cleaning Validation · Recovery · Analytical Methods · Acceptance Criteria
Article · Other
The three-run cleaning validation was never a requirement — it was the convention that grew where guidance was silent. PI 006-4, the ASTM cleaning standards and three recent FDA warning letters all point at the same thing: what has to be maintained is a validated state, and continued cleaning verification is how you know it still holds.
Primary source ↗Cleaning Validation · Worst Case · Acceptance Criteria · Revalidation
Article · Other
A maximum allowable carry-over value is a PDE multiplied by a set of process assumptions — batch size, dose, surface area, recovery and the cleaning step itself. Read as a body of evidence, the 2025–2026 enforcement record is rarely about toxicity assessment, and almost always about those assumptions.
Primary source ↗Cleaning Validation · HBEL & PDE · MACO · Recovery · Acceptance Criteria
Article · Other
Separate the source, its scope and the decision you need to make.
Article · Other
A practical approach to connecting equipment, locations and samples.
Article · Other
Make the link between test surfaces and routine sampling explicit.
Article · Other
Define the events behind the timestamps before evaluating the interval.
Article · Other
Follow a proposed change across the evidence that supports routine use.
Article · EU GMP
PIC/S has published PI 006-4, the revised Recommendations on Qualification and Validation, superseding the 2007 PI 006-3 and entering into force on 1 October 2026. Cleaning validation now occupies a full chapter, with HBEL-driven scope, explicit limits on visual inspection and a clear position against continued test-until-clean practice.
Primary source ↗Cleaning Validation · HBEL & PDE · MACO · Recovery · Swab Sampling · Rinse Sampling · Worst Case · Visual Inspection · Hold Times · Analytical Methods · Acceptance Criteria · Revalidation · Microbial Control · Detergents
Article · Other
FDA connects unvalidated cleaning on shared equipment with interim measures and the assessment of distributed products.
Article · FDA
A 2026 FDA warning letter to Dabur India rejects a shared-equipment cleaning programme that relied exclusively on visual inspection. The objection is narrower than it appears — and it turns on missing quantitative limits, not on visual inspection itself.
Primary source ↗Cleaning Validation · MACO · Swab Sampling · Visual Inspection · Acceptance Criteria
Article · FDA
Twelve FDA warning letters issued between 3 December 2024 and 24 July 2026 cite cleaning and cross-contamination control. Read together rather than case by case, they stop looking like twelve incidents and start looking like one audit checklist: worst-case selection, hold times, recovery, MACO justification, visual-only strategies, sampling locations, change control and lifecycle management — in that order of frequency.
Primary source ↗Cleaning Validation · MACO · Recovery · Swab Sampling · Worst Case · Visual Inspection · Hold Times · Shared Equipment · Revalidation
Article · EMA
EMA and PIC/S reissued the January 2026 Annex 15 concept paper in July 2026 with a new reference number and a substantially longer timetable. Nothing about cleaning validation itself changed — but the dates most teams are planning against did.
Primary source ↗Cleaning Validation · Hold Times · Revalidation
Article · Other
Antibody-drug conjugates combine a biologic, a chemical linker and a cytotoxic payload on shared equipment. A STERIS webinar frames the problem; independent guidance shows why one product-specific assay no longer answers the question.
Primary source ↗Cleaning Validation · HBEL & PDE · MACO · Recovery · Worst Case · Analytical Methods · Shared Equipment
Article · Other
An evergreen source briefing on the distinction between the safety basis and routine cleaning limits.
Article · FDA
FDA's 1 May 2026 warning letter to Harbin Jixianglong Biotech found a cleaning procedure that required a toxicity-based carryover limit, and a validation study that established none — with no justification for swab locations and no swab results.
Primary source ↗Cleaning Validation · HBEL & PDE · MACO · Swab Sampling · Analytical Methods · Shared Equipment
Article · Other
Observed residues and the response to them put cleaning effectiveness and product-impact assessment in focus.
Article · Other
A comparative review in the PDA Journal weighs worst-case matrices against product-specific validation and proposes a hybrid model anchored on visible residue limits.
Primary source ↗Cleaning Validation · HBEL & PDE · Worst Case · Visual Inspection · Acceptance Criteria · Shared Equipment · Revalidation
Article · Other
A visible-residue observation illustrates the gap between a clean-status label and demonstrated cleaning effectiveness.
Article · FDA
An FDA investigator found white residue inside Tank #68 at Chemco Corporation — equipment the quality unit had already verified as clean. The finding itself is mundane. What it exposes about release decisions, shared equipment and the absence of cleaning validation is not.
Primary source ↗Cleaning Validation · Visual Inspection · Shared Equipment · Revalidation
Article · Other
The letter links equipment cleaning, drying and microbial contamination risk in sterile manufacturing.
Article · EU GMP
A joint EMA–PIC/S concept paper proposes extending Annex 15 to active substance manufacturers and aligning it with ICH Q9(R1). The current Annex 15 stays in force, and the earliest a revised text could be published is 2028.
Primary source ↗Cleaning Validation · Worst Case · Visual Inspection · Hold Times · Analytical Methods · Acceptance Criteria · Shared Equipment · Revalidation
Article · FDA
FDA's Warning Letter 320-26-43 to Cosmetic Manufacturers (Aust) Pty Ltd. states that the firm's cleaning validation protocol 'was not designed to demonstrate reproducibility'. The cause is a design flaw that is easy to copy by accident: each qualification run sampled a different set of locations, so the runs were never replicates of the same measurement.
Primary source ↗Cleaning Validation · Swab Sampling · Worst Case · Shared Equipment
Article · FDA
FDA Warning Letter 320-26-40 to Cohance Lifesciences did not turn on a single residue number. It turned on whether the firm's verification programme could have found the carryover at all — and whether its worst-case basis was ever revisited.
Primary source ↗Cleaning Validation · Worst Case · Analytical Methods · Shared Equipment · Revalidation
Article · Other
A January 2026 AAPS PharmSciTech paper proposes normalising every residue result to a percentage of its own specification limit, so that cleaning data from different products can finally be pooled, analysed non-parametrically and monitored as a Stage 3 capability index. The statistical argument is the substance; the AI framing is thinner than the title suggests.
Primary source ↗Cleaning Validation · MACO · Swab Sampling · Analytical Methods · Acceptance Criteria · Revalidation
Article · FDA
FDA's December 2025 letter to Medinatura New Mexico records a firm acknowledging that its cleaning validation was not reflective of current operations after years of buying new equipment and adding new products. What the gap looks like from the inside — and what it asks of change control.
Primary source ↗Cleaning Validation · Worst Case · Hold Times · Shared Equipment · Revalidation
Article · Other
A BeNeLux ISPE event on 23 September 2025 put 'business continuity' and 'culture' next to 'compliance' in the same talk title. That framing is the story: cleaning validation is being repositioned as an operational capability that keeps multi-product campaigns running, not a documentation obligation discharged before an inspection.
Primary source ↗Cleaning Validation · Worst Case · Shared Equipment
Article · FDA
The FDA's August 2025 warning letter to ABBE Laboratories describes a 2009 cleaning validation still standing while a harder-to-clean product was introduced onto the same shared kettle — and no change-control step that caught it.
Primary source ↗Cleaning Validation · Worst Case · Hold Times · Analytical Methods · Acceptance Criteria · Shared Equipment · Revalidation
Article · Other
A STERIS-authored article in Pharmaceutical Technology reports that in-line UV spectrometry at 220 nm can follow a biopharmaceutical cleaning cycle continuously, from heavily soiled rinse to baseline. The data are encouraging, the framing is vendor-supplied, and the distance between process monitoring and a release decision is where our own thinking has to do the work.
Primary source ↗Cleaning Validation · Rinse Sampling · Worst Case · Analytical Methods · Acceptance Criteria
Article · Other
A 2025 DARU Journal of Pharmaceutical Sciences study builds a structured cleaning-validation protocol for QC-lab glassware and stainless-steel equipment, using oxcarbazepine as worst-case API and pairing HPLC residue analysis with conductivity and TOC detergent checks.
Primary source ↗Cleaning Validation · Recovery · Swab Sampling · Rinse Sampling · Worst Case · Analytical Methods · Acceptance Criteria · Shared Equipment
Article · Other
ASTM International has published E3470-25, a first-edition guide on using FMECA and HACCP/HARPC to identify, analyse and control risk in pharmaceutical and medical device cleaning processes. It is the method layer that E3106 required but did not fully specify.
Primary source ↗Cleaning Validation · Acceptance Criteria · Microbial Control · Detergents
Article · EMA
ASTM has re-issued E3219 as E3219-25, the current reference for deriving health-based exposure limits. HBELs are a decade-old regulatory expectation, not a 2025 novelty — but the revision sharpens how limits are derived, documented and defended.
Primary source ↗Cleaning Validation · HBEL & PDE · MACO · Acceptance Criteria
Article · Other
TOC can live on the QC bench, on the shop floor next to the vessel, or plumbed into the CIP skid. The instrument is the same; the sampling chain — and therefore the meaning of the number — is not.
Primary source ↗Cleaning Validation · Swab Sampling · Rinse Sampling · Analytical Methods
Article · Other
A lightning talk at PDA Week 2025 argued for a lean approach to analytical panels in cleaning validation. The independent framework to justify it already exists in ASTM E3106 and ICH Q9(R1) — but only if the arithmetic is documented.
Primary source ↗Cleaning Validation · HBEL & PDE · Visual Inspection · Analytical Methods · Acceptance Criteria
Article · Other
INTERPHEX 2025 in New York put cleaning validation on the process-monitoring agenda: a dedicated panel on analytics, contamination control and sustainability, plus cleanroom and environmental-monitoring sessions. Industry-press report from Javits Center, 1-3 April 2025.
Primary source ↗Cleaning Validation · MACO · Analytical Methods · Acceptance Criteria · Revalidation
Article · FDA
A March 2025 FDA warning letter to Aspen Biopharma Labs Private Limited records investigators finding manufacturing equipment labelled "Cleaned" while liquid with a floating substance or residue remained on product-contact surfaces. That gap between a status tag and physical reality is one of the most consequential — and most preventable — failures in cleaning validation.
Primary source ↗Cleaning Validation · Visual Inspection · Acceptance Criteria · Shared Equipment
Article · FDA
The FDA rejected a retrospective MACO argument in a February 2025 warning letter — not because the arithmetic was wrong, but because the cleaning it assumed had not been performed. What cleaning-validation teams can take from it.
Primary source ↗Cleaning Validation · MACO · Recovery · Swab Sampling · Worst Case · Hold Times · Shared Equipment · Microbial Control
Article · FDA
In Warning Letter 320-25-38 the FDA did not attack visual inspection as a technique. It objected to a cleaning programme in which visual inspection was the only evidence on the table — no acceptance criteria for carryover residues, no analytical data, and no procedures for the rest of the equipment train.
Primary source ↗Cleaning Validation · Visual Inspection · Analytical Methods · Acceptance Criteria
Article · Other
A NIPER-Ahmedabad group pairs a validated RP-HPLC surface-residue method for three SGLT-2 inhibitors with a detoxification strategy for the resulting cleaning waste.
Primary source ↗Cleaning Validation · Recovery · Swab Sampling · Analytical Methods · Acceptance Criteria · Detergents
Article · FDA
A December 2024 warning letter to Brands International Corporation cites the firm under 21 CFR 211.67(b) for failing to perform cleaning validation studies on non-dedicated equipment — and asks for a cleaning programme built around worst-case products, worst-case swab sites and maximum hold times before cleaning.
Primary source ↗Cleaning Validation · Worst Case · Shared Equipment · Revalidation
Article · FDA
An FDA Warning Letter to Indian API manufacturer Micro Orgo Chem describes non-dedicated equipment that had never been cleaned under a validated procedure, cleaning SOPs that were not followed, and no evidence that the rinse and swab samples required by the firm's own procedure were ever collected or tested.
Primary source ↗Cleaning Validation · Swab Sampling · Rinse Sampling · Worst Case · Visual Inspection · Hold Times · Shared Equipment · Revalidation · Microbial Control
Article · Other
ASTM work item WK92658 wants to standardise how cleaning processes are judged capable — one-sided limits, small data sets, non-normal residues and continued verification included. It is the statistical gap E3106 left open.
Primary source ↗Cleaning Validation · Swab Sampling · Worst Case · Analytical Methods · Acceptance Criteria · Revalidation
Article · Other
A bench-scale study puts the 650 ug/dose parenteral PDE for cleaning-induced protein degradants to the test with human-cell immunogenicity assays on HLE BiTE and mAb degradants, spiked into the same and a cross product.
Primary source ↗Cleaning Validation · HBEL & PDE · MACO · Worst Case · Analytical Methods · Acceptance Criteria · Shared Equipment
Article · Other
ASTM Work Item WK92599 would give total organic carbon analysis its own dedicated guidance for swab and rinse samples — and force cleaning programmes to defend recovery and limits, not just concentrations.
Primary source ↗Cleaning Validation · Swab Sampling · Rinse Sampling · Analytical Methods
Article · Other
A German hospital-pharmacy study argues blister-machine cleaning is a mandatory duty of care, and shows UV-Vis spectroscopy can replace HPLC as the analytical method.
Primary source ↗Cleaning Validation · Analytical Methods · Acceptance Criteria · Shared Equipment
No matching results. Try a broader term or clear a filter.
Looking for original documents? Browse the official source library ↗